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Defective autophagy is increasingly implicated in the path-
ogenesis of pancreatitis. Here we show that lysosome-
associated membrane proteins (LAMPs) are degraded in
experimental and human pancreatitis; LAMP-2 maintains
acinar cell homeostasis, and its genetic ablation causes
impaired autophagy and spontaneous pancreatitis.
BACKGROUND & AIMS: The pathogenic mechanism of
pancreatitis is poorly understood. Recent evidence implicates
defective autophagy in pancreatitis responses; however, the
pathways mediating impaired autophagy in pancreas remain
largely unknown. Here, we investigate the role of lysosome
associated membrane proteins (LAMPs) in pancreatitis.
METHODS: We analyzed changes in LAMPs in experimental
models and human pancreatitis, and the underlying mecha-
nisms: LAMP deglycosylation and degradation. LAMP cleavage
by cathepsin B (CatB) was analyzed by mass spectrometry. We
used mice deficient in LAMP-2 to assess its role in pancreatitis.
RESULTS: Pancreatic levels of LAMP-1 and LAMP-2 greatly
decrease across various pancreatitis models and in human
disease. Pancreatitis does not trigger the LAMPs’ bulk degly-
cosylation but induces their degradation via CatB-mediated
cleavage of the LAMP molecule close to the boundary be-
tween luminal and transmembrane domains. LAMP-2 null mice
spontaneously develop pancreatitis that begins with acinar cell
vacuolization due to impaired autophagic flux, and progresses
to severe pancreas damage characterized by trypsinogen acti-
vation, macrophage-driven inflammation, and acinar cell death.
LAMP-2 deficiency causes a decrease in pancreatic digestive
enzymes content, and stimulates the basal and inhibits
cholecystokinin-induced amylase secretion by acinar cells. The
effects of LAMP-2 knockout and acute cerulein pancreatitis
overlap, which corroborates the pathogenic role of LAMP
decrease in experimental pancreatitis models.
CONCLUSIONS: The results indicate a critical role for LAMPs,
particularly LAMP-2, in maintaining pancreatic acinar cellhomeostasis and provide evidence that defective lysosomal
function, resulting in impaired autophagy, leads to pancreatitis.
Mice with LAMP-2 deficiency present a novel genetic model of
human pancreatitis caused by lysosomal/autophagic dysfunc-
tion. (Cell Mol Gastroenterol Hepatol 2015;1:678–694; http://
dx.doi.org/10.1016/j.jcmgh.2015.07.006)
Keywords: Amylase Secretion; Autophagy; Cathepsin B;
Cerulein.
ancreatitis is a potentially fatal disease withPconsiderable morbidity and mortality, the patho-
genesis of which remains obscure and for which no specific
or effective treatment has been developed.1,2 Accumulation
of large vacuoles in acinar cells, the main exocrine pancreas
cell type, is a long-noted but poorly understood feature of
both experimental and human pancreatitis.3–6 Evidence
from the past several years indicates that these vacuoles are
mostly autolysosomes, and their accumulation is a result of
impaired autophagic flux.6–9 Autophagy comprises several
intracellular pathways of lysosome-mediated degradation
and recycling of organelles, long-lived proteins, and lip-
ids.10–12 Its major pathway, macroautophagy (hereafter
November 2015 LAMP-2 Deficiency Causes Pancreatitis 679referred to as autophagy) begins with the formation of
autophagosomes that sequester material destined for
degradation. Autophagosomes ultimately fuse with lyso-
somes, generating autolysosomes in which cargo is
degraded by lysosomal hydrolases such as cathepsins.
Although autophagy is increasingly implicated in the
mechanism of pancreatitis,6–9,13 the pathways leading to its
impairment in the pancreas remain largely unknown.
Because autophagy is lysosome driven, one mechanism of
impaired autophagic flux could be defective function of ly-
sosomes. Lysosome-associated membrane proteins (LAMPs)
play critical and diverse roles in the function of lyso-
somes.14,15 LAMP-1 and LAMP-2 are heavily glycosylated
proteins and major constituents of the glycoconjugate coat
on the inside of the lysosomal membrane.15,16 LAMPs pro-
tect the cytoplasm and the limiting lysosomal membrane
itself from the action of acid hydrolases, and they regulate
the fusion of lysosomes with other organelles (in particular
autophagosomes), lysosomal proteolytic activity, and phag-
ocytosis.14,15,17–19 The LAMP-2a isoform acts as a specific
translocation receptor in chaperone-mediated autophagy.20
LAMP-2 deficiency in mice results in cardiomyopathy, rep-
resenting a model of Danon disease.14,18 Although vacuole
accumulation has been reported in pancreas of LAMP-2 null
mice,18 the consequences of LAMP deficiency for exocrine
pancreas have not been explored.
Here, we show that pancreatic levels of LAMP-1 and
LAMP-2 proteins decrease across various experimental
models of nonalcoholic and alcoholic pancreatitis, as well as
in human disease. Our data, including mass spectrometry
(MS), indicate that LAMPs’ decrease in pancreatitis is caused
by their degradation mediated by cathepsin B. We find that
LAMP-2 null mice spontaneously develop pancreatitis and
that LAMP-2 deficiency causes dysregulation of amylase
secretion from acinar cells. The results indicate a critical role
of lysosomal/autophagic pathways for the exocrine pancreas.Materials and Methods
Experimental Pancreatitis
Acute cerulein (CR) pancreatitis was induced, as
described elsewhere,6,21–24 in male Sprague-Dawley rats and
in C57BL/6 and LAMP-2 null mice of both sexes that
received hourly intraperitoneal (IP) injections of 50 mg/kg
CR; the controls received similar injections of physiologic
saline. If not stated otherwise, rats were euthanized 4 hours
and mice 7 hours after the first injection. L-Arginine (Arg)
pancreatitis was induced in rats of both sexes by 2 hourly IP
injections of 2.5 g/kg Arg; the controls received similar in-
jections of saline.6,22 The animals were euthanized 24 hours
after the first injection. Choline-deficient, ethionine-supple-
mented (CDE) pancreatitis was induced in young (w5-weeks
old) female mice fed either CDE or control diet.6,22 Mice were
euthanized 72 hours after initiation of the diet. Ethanol plus
low-dose CR pancreatitis25 was induced in rats that were fed
for 6 weeks Lieber-DeCarli ethanol-containing diet and then
received four hourly IP injections of either saline or low-dose
(0.5 mg/kg) CR; this dose of CR does not induce pancreatitis
responses in rats fed isocaloric control diet.All experimental protocols were approved by animal
research committees of VA Greater Los Angeles Healthcare
System and Ernst-Moritz-Arndt-University (Greifswald,
Germany), in accordance with U.S. National Institutes of
Health guidelines.
Genetically Modified Mice
Mice deficient in LAMP-2, cathepsin B (CatB), or CatD
have been described elsewhere.14,15,18,23,26
Human Pancreas Specimens
Samples of human normal pancreas and pancreatitis
were evaluated for the presence of acinar compartment and
provided deidentified by Pancreas Tissue Bank of the Uni-
versity of California at Los Angeles (UCLA) Department of
Pathology (D.D.) according to a protocol approved by the
UCLA institutional review board.
Isolation of Pancreatic Acinar Cells and Lobules
Pancreatic acinar cells were isolated from wild-type and
LAMP-2 null mice using a standard collagenase digestion
procedure6,23 and maintained in Dulbecco’s modified Eagle
medium containing 2% bovine serum albumin, and 10 mM
HEPES. Pancreatic lobules were prepared27 by injecting into
freshly dissected pancreas of a buffer consisting of (mM) 10
HEPES, 137 NaCl, 4.7 KCl, 0.56 MgCl2, 1.28 CaCl2, 0.6
Na2HPO4, 5.5 D-glucose, 2 L-glutamine, and essential amino
acids solution. The buffer was supplemented with 0.1 mg/mL
soybean trypsin inhibitor and 1 mg/mL bovine serum albu-
min, adjusted to pH 7.4, and gassed with 100% O2. The
lobules (w2-mm thick) were then excised and incubated at
37C in 199 medium containing 0.1 mg/mL soybean trypsin
inhibitor in the presence or absence of cholecystokinin (CCK)
and other agents as indicated.
Preparation of Tissue and Cell Lysates, and
Membrane and Cytosolic Fractions
Portions of frozen tissue or lobules were homogenized on
ice in radioimmunoprecipitation assay buffer supplemented
with 1 mM phenylmethylsulfonyl fluoride and protease in-
hibitors’ cocktail. Supernatants were collected and stored
at 80C. Protein concentration in the supernatants was
determined by Bradford assay (Bio-Rad Laboratories, Her-
cules, CA). To obtain cytosolic and membrane fractions,
pancreatic tissue was homogenized in a buffer containing 25
mM Tris-HCl (pH 7.4), 150 mM NaCl, 1 mM MgCl2, and pro-
tease inhibitor cocktail. Postnuclear supernatant was centri-
fuged for 2 hours at 150,000g, and both the pellet (membrane
fraction) and supernatant (cytosolic fraction) were collected
separately and used for the immunoblot analysis.
Preparation of Lysosome-Enriched Fraction
The pancreas was dissected, homogenized in four vol-
umes of extraction buffer (5 mM MES, pH 7.0, 250 mM su-
crose, 1 mM MgSO4, and protease inhibitor cocktail) per
gram of tissue, and the homogenate was centrifuged at
1000g for 10 minutes at 4C. Postnuclear supernatant was
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the pellet (crude lysosomal fraction) was collected, incu-
bated with 8 mM CaCl2 to precipitate mitochondria and
endoplasmic reticulum, and then centrifuged at 5000g for
10 minutes. The lysosome-containing supernatant28 was
stored at 80C. The absence of cyclooxygenase IV (COX IV)
in the cytosolic and lysosome-enriched fractions, and lack of
lactate dehydrogenase in the membrane fraction were used
to evaluate the quality of subcellular fractionation and the
degree of enrichment.
Immunoblot Analysis
Proteins in pancreatic tissue and cell homogenates or
cytosolic and membrane fractions were separated by so-
dium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE). Blots were developed for visualization using
enhanced chemiluminescence detection kit (Pierce
Biotechnology, Rockford, IL); band intensities were quanti-
fied by densitometry using the FluorChem HD2 imaging
system (Alpha Innotech/ProteinSimple, San Jose, CA).
Antibodies
We used Abs against the C-terminal region of rat and
mouse LAMP-1 (ab24170; Abcam, Cambridge, MA), LAMP-2
(L0668; Sigma-Aldrich, St. Louis, MO), LAMP-2a (51-2200;
Invitrogen/Life Technologies, Carlsbad, CA), and lysosomal
integral membrane protein type-2 (LIMP-2) (NB400-129;
Novus Biologicals Oakville, ON, Canada); and against full-
length/luminal mouse LAMP-1 (1d4b; Iowa Developmental
Studies Hybridoma Bank, University of Iowa, Iowa City, IA),
and mouse LAMP-2 (GL2A7; Iowa Developmental Studies
Hybridoma Bank). The following Abs were used for immu-
nofluorescence and immunohistochemical analyses:
collagen-1 (ab292; Abcam), Ki67 (IHC-00375; Bethyl Labo-
ratories, Inc. Montgomery, TX), a-smooth muscle actin
(a-SMA) (clone 1A4; Sigma-Aldrich), insulin (4590; Cell
Signaling Technology, Beverly, MA), CD68 (ABIN181836;
Antibodies Online, Atlanta, GA), and CD206 (OASA05048;
Aviva Systems Biology, San Diego, CA).
Light and Fluorescence Microscopy
Histochemical staining (H&E, Goldner trichrome) and
immunostaining for a-SMA, collagen-1, Ki67, LAMPs, and
CatD was performed on paraffin-embedded pancreas tissue
sections using Target Retrieval buffer (Dako, Carpinteria,
CA). Immunostaining for macrophages (CD68 and CD206)
was performed on cryosections. Images were acquired with
a Nikon Eclipse TE2000-S microscope (Nikon Instruments,
Melville, NY) equipped with a charge-coupled device (CCD)
camera, using the SPOT imaging software (SPOT Imaging
Solutions, Sterling Heights, MI), or with a Zeiss LSM 710
confocal microscope using 63 objective (Carl Zeiss Light
Microscopy, Göttingen, Germany). Nuclei were counter-
stained with 40,6-diamidino-2-phenylindole (DAPI). To
determine the percentage of colocalization of two proteins,
images obtained with the use of corresponding antibodies
were loaded into the ImageJ software (http://imagej.nih.
gov/ij/); the ratios of green (fluorescein isothiocyanateconjugated secondary antibody) or red (Texas Red conju-
gated secondary antibody) cells to merged cells were
determined using the colocalization plug-in. The quantifi-
cation of immunohistochemical images was performed as
described by Sendler et al.24
Transmission Electron Microscopy and
Immunogold Electron Microscopy
The tissue was cut into 1-mm cubes and fixed at 4C in
2.5% glutaraldehyde in 0.15 M sodium cacodylate (pH 7.4)
overnight. After fixation in 1% OsO4 followed by uranyl
acetate, tissue was dehydrated in ethanol and embedded in
epoxy resin. We examined 100-nm-thick sections in a
Hitachi-600 electron microscope (Hitachi High Technologies
America, Schaumburg, IL). For Immunogold EM (electron
microscopy), the rats were perfused with either 2% wt/vol
paraformaldehyde (PFA) in 0.1 M phosphate buffer (pH 7.4)
or 2% wt/vol PFA, 0.2% wt/vol glutaraldehyde in 0.1 M
phosphate buffer, pH 7.4. After the perfusion fixation with
2% PFA, the tissues were removed and immediately
immersed in 4% wt/vol PFA in 0.1 M phosphate buffer and
kept overnight at 4C.
The fixed tissues were further processed for cry-
osectioning and Immunogold EM as described elsewhere.29
In brief, ultrathin cryosectioning was performed at 120C
in a Leica UCT-FCS ultracryomicrotome (Leica Micro-
systems, Buffalo Grove, IL). The sections were transferred to
copper grids by pickup with a 1:1 mixture of 2.3 M sucrose
in phosphate-buffered saline (PBS) and 2% wt/vol methyl
cellulose. The grids were incubated first on 2% gelatin/PBS
at 37C, blocked with 0.02 M glycine/PBS and 1% bovine
serum albumin/PBS, and subsequently incubated with pri-
mary antibodies followed by protein A-gold (Cell Micro-
scopy Centre, UMC Utrecht, the Netherlands). The sections
were contrasted with 2% uranyl acetate/oxalate.
Glycosidase Treatment
Proteins in pancreatic membrane fractions were dena-
tured by incubation at 80C for 5 minutes in the presence of
0.5% sodium dodecyl sulfate, and then treated with pepti-
de:N-glycosidase (PNGase) F from Flavobacterium menin-
gosepticum (New England BioLabs, Ipswich, MA) or with
endonuclease H from Streptomyces plicatus (Glyko, Pro-
Zyme, Hayward, CA) at 37C for 1 or 3 hours, respectively,
according to the manufacturers’ protocols. Incubation with
Jack bean a-mannosidase (Sigma-Aldrich) was performed in
25 mM sodium acetate buffer (pH 5.0) containing 1% Triton
X-100 at 37C for 3 hours.
Cleavage of rLAMP-1 by CatB
Before use, recombinant mouse CatB (R&D Systems,
Minneapolis, MN) was activated by 30 minutes of incubation
with 1 mM dithiothreitol on ice. CatB-induced conversion of
trypsinogen (Sigma-Aldrich) to trypsin6 served as a positive
control for its full activity. Recombinant mouse LAMP-1
(rLAMP-1, 2 mg/mL; R&D Systems) was incubated with
activated CatB in 25 mM MES, 2 mM dithiothreitol, pH 5.0,
for 1 hour at 30C, and changes in rLAMP-1 level were
measured by immunoblot. The rLAMP-1 peptides generated
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(Stanford University Mass Spectrometry Core) using an LTQ
Orbitrap Velos MS (Thermo Fisher Scientific, Waltham, MA)
set in high-high data-dependent mode to fragment, via higher
energy collisional dissociation (HCD), the top eight most
intense precursor ions. The data were analyzed both manu-
ally and by Sequest on a Sorcerer station (Sage-N Research,
Seattle, WA).
Pancreatitis Parameters
Serum amylase was measured in a Hitachi 707 analyzer
(Antech Diagnostics, Irvine, CA). Trypsin activity was
measured in tissue and cell homogenates, as described
elsewhere,6,23,24,26 using specific fluorogenic substrate Boc-
Gln-Ala-Arg-AMC (Sigma-Aldrich) or R110-Ile-Pro-Arg
(Invitrogen/Life Technologies). Trypsin activity in each
sample was determined using a standard curve for purified
trypsin (Worthington Biochemical, Lakewood, NJ). To mea-
sure the total amount of trypsinogen, the homogenate was
incubated with 0.2% (wt/vol) enterokinase in 100 mM Tris-
HCl buffer (pH 8.0; 37C; 1 hour) to convert all trypsinogen
to trypsin, followed by measurement of trypsin activity.
Myeloperoxidase (MPO) activity was measured as
described elsewhere.24 Pancreatic tissue was homogenized
on ice in 20 mM potassium phosphate buffer (pH 7.4) and
centrifuged at 4C. The pellet was resuspended in 50 mM
potassium phosphate buffer (pH 6.0) containing 0.5%
cetyltrimethyl ammonium bromide, 10 mM phenyl-
methylsulfonyl fluoride, and 10 mM soybean trypsin inhib-
itor. The suspension was freeze-thawed in cycles, sonicated,
and centrifuged at 20,000g and 4C. MPO activity was
assayed in 50 mM potassium phosphate buffer (pH 6.0)
containing 0.53 mM O-dianisidine and 0.15 mM H2O2. The
initial increase in absorbance was measured at 30C in a
SpectraMax spectrophotometer (Molecular Devices, Sunny-
vale, CA). The results are expressed in units of MPO activity
per total protein, using purified MPO (Calbiochem/EMD
Millipore, San Diego, CA) as a standard.
Caspase-3 activity was measured in pancreatic tissue ho-
mogenates by a fluorometric assay using R110-DEVD sub-
strate (Invitrogen/Life Technologies). Amylase release was
measured from acinar cells incubated for 30minuteswith and
without CCK-8 at various concentrations. Values are the ratio
between the amount of amylase released into the medium
[measured with a photometric assay (Roche-Hitachi, Rotk-
reuz. Switzerland)] and the total cellular amylase determined
by permeabilizing cells with 1% Triton X-100.
Acinar cell vacuolization, necrosis, apoptosis, and inflam-
matory cell infiltration were quantified on H&E stained
pancreatic tissue sections. At least 1000 acinar cells/mouse
were analyzed on several high-power fields. Necrosis was
measured either as percentage of necrotic cells/100 acinar
cells or graded on 0–4 scale on 400 high-power fields.
Apoptosis was measured with a terminal deoxynucleotidyl
transferase–mediated deoxyuridine triphosphate nick-end
labeling (TUNEL) assay (Promega, Madison, WI). Macro-
phages were further quantified by immunostaining for CD68
and CD206 markers; chloroacetate esterase staining was
used for neutrophils.Statistical Analysis
Data are expressed as mean ± standard error of the
mean (SEM). Statistical analysis was performed on Prism 5
software (GraphPad Software, San Diego, CA), using two-
tailed, unpaired Student t test for comparisons between
two groups. P < .05 was considered statistically significant.
Results
LAMP-1 and LAMP-2 Decrease in Experimental
and Human Pancreatitis
Immunoblot analysis (Figure 1A and B and Figure 2A–C)
showed a pronounced decrease in pancreatic levels of
LAMP-1 and LAMP-2 in five dissimilar rat and mouse
models of acute pancreatitis, namely, those induced by
administration of supramaximal CR (analog of CCK-8) or
L-arginine (Arg); by CDE diet; or by ethanol feeding com-
bined with low-dose CR (see Materials and Methods). Ethanol
feeding alone caused some decrease in pancreatic LAMPs,
but much less than in ethanol þ low-dose CR pancreatitis
(Figure 1A). Pancreatitis-induced decreases were observed
for LAMP isoforms mediating macroautophagy and for
LAMP-2a, the isoform mediating chaperone-mediated auto-
phagy; however, there was no effect on LIMP-2, a member of
another family of lysosomal membrane proteins
(Figure 2A–C). The down-regulation of LAMPs occurred
early in the course of pancreatitis; it was already prominent
at 30 minutes after induction of CR pancreatitis (Figure 1A).
Immunogold-EM localized LAMPs in normal pancreas to
acinar cell lysosomes and autolysosomes (Figure 1C).
Accordingly, immunofluorescence showed punctate LAMP
staining in acinar cells of normal human (Figure 1D) and rat
(Figure 2D) pancreas. Although LAMPs retained their lyso-
somal/autolysosomal localization in pancreatitis
(Figure 1C), the number of LAMP puncta greatly decreased
in both human (Figure 1D) and experimental (Figure 2D)
pancreatitis, in accord with the immunoblot data. Notably,
immunolabeling for the lysosomal marker CatD was not
affected in either human or experimental pancreatitis
(Figure 1D and Figure 2D). However, the extent of CatD
colocalization with LAMP-2 was markedly reduced in
pancreatitis (Figure 1D and E; Figure 2D and E), indicating a
selective LAMP decrease in lysosomes. This conclusion is
supported by immunoblot analysis (Figure 2B and C; and
data not shown) showing that 1) in both control and
diseased pancreas, LAMPs were only present in the mem-
brane but not cytosolic fractions; 2) pancreatitis decreased
LAMP levels in membrane fractions and in lysosome
enriched fraction; and 3) pancreatitis had much less effect
on LIMP-2, including in the lysosome-enriched fraction.
Pancreatitis Preferentially Affects LAMPs
C Terminus
The LAMP molecule is composed of a large luminal
ectodomain, the transmembrane domain, and a very small
(11 aa) C-terminal cytoplasmic tail.14–17 We observed that
the extent of the LAMP decrease in pancreatitis was
different in immunoblots obtained on the same samples
using Abs against LAMP C terminus versus Abs that
Figure 1. Pancreatic levels of lysosome-associated membrane protein 1 (LAMP-1) and LAMP-2 decrease in rodent
models and human pancreatitis. Pancreatitis was induced in rats by administration of cerulein (CR) or L-arginine (Arg), or by a
combination of ethanol diet (EtOH) and low-dose CR; and in mice, by CR or feeding choline-deficient ethionine supplemented
(CDE) diet (see Materials and Methods). (A, B). Immunoblot analysis of pancreatic LAMP levels in fully developed pancreatitis
and at the onset (after 30 minutes) of CR pancreatitis, using Abs against the C terminus of LAMP-1 (Abcam) and LAMP-2
(Sigma). In this and other figures, extracellular signal-activated kinases 1/2 (ERK1/2), b-actin, or glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) are loading controls; each lane represents an individual animal; the data are represen-
tative of several immunoblots from at least three animals for each condition; the narrow white space on the immunoblot
indicates that the lanes are on the same blot but not contiguous. (B) The densitometric intensity of LAMP band was normalized
to that of ERK in the same sample, and the mean LAMP/ERK ratio in pancreatitis group was further normalized to that in
control group. Values are mean ± SEM (n ¼ 4 per group). (C). Immunogold electron microscopy labeling shows LAMP-1 in
lysosomes (L) and autolysosomes (AL) in pancreas of rats with CR pancreatitis and control (saline). The asterisks point to
remnants of sequestered organelles. Scale bar: 500 nm. (D, E). Immunofluorescence analysis of LAMP-2 (using the C-terminal
Ab) and cathepsin D (CatD) in human pancreas. Nuclei staining with 40,6-diamidino-2-phenylindole (DAPI) (blue; not shown in
“merge” panels). DIC, differential interference contrast, which prominently displays zymogen granules area in acinar cells.
Scale bar: 10 mm (all images). (E) LAMP-2 punctate staining and colocalization of CatD with LAMP-2 in human normal
pancreas and pancreatitis were quantified with ImageJ. Values are mean ± SEM from four normal and seven pancreatitis tissue
samples from different patients. *P < .05 versus normal pancreas.
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Figure 2. Experimental pancreatitis causes a decrease in lysosome-associated membrane proteins (LAMPs), including
LAMP-2a, but not in lysosomal integral membrane protein type-2 (LIMP-2). Cerulein (CR) pancreatitis was induced in mice
(A–C) and rats (D). Pancreatic levels of indicated proteins were measured by immunoblot, using C-terminal Abs, in (A) whole
tissue homogenates, (B) membrane and cytosolic fractions, and (C) lysosome-enriched fraction (see Materials and Methods).
Extracellular signal-activated kinases 1/2 (ERK1/2), lactate dehydrogenase, and cyclooxygenase IV (COX IV) served as con-
trols for equal loading and the quality of subcellular fractionation. Data in B and C are representative of two independent
experiments, with similar results. (D) Colocalization of LAMP-2 and cathepsin D (CatD) in pancreas of control (saline) rats and
rats with CR pancreatitis. Tissue sections were double immunostained for LAMP-2 (using C-terminal Ab) and CatD. Insets
show higher magnification for the areas in smaller boxes. Scale bar is the same for all images. DIC, differential interference
contrast. (E). CatD colocalization with LAMP-2 was quantified with ImageJ. Values are mean ± SEM (n ¼ 3–4 per group);
*P < .05 versus control.
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In control pancreas, both types of antibodies showed LAMP
bands of similar intensity (Figure 3A and B). This was not
the case in pancreatitis models: pancreatitis-induced de-
creases in LAMP-1 and LAMP-2 were much greater with C-
terminal Abs than with Abs against LAMP luminal part
(Figure 3A–C). Compared with whole tissue, these differ-
ences were even more pronounced in lysosome-enriched
fraction (Figure 3D). Moreover, a slight shift in the posi-
tion of LAMP band recognized by the two types of Abs was
observed in pancreatitis samples on some immunoblots, as
illustrated in Figure 3D. These results indicate that
pancreatitis preferentially affects LAMP C terminus so that
LAMPs cease to be recognizable by C-terminal Abs.Pancreatitis Does Not Cause Bulk
LAMP Deglycosylation
A logical explanation for the observed preferential effect
on the LAMP C terminus is that pancreatitis causes the
degradation of LAMPs. One possible underlying mechanism
could be LAMP deglycosylation, which decreases the sta-
bility of LAMP-1 and LAMP-2 proteins.30 However, ourresults (Figure 4) argue against such possibility. In both
controls and pancreatitis, immunoblot with either C-termi-
nal or luminal Abs did not show the lower molecular mass
LAMP bands indicative of accumulation of under- or
deglycosylated molecules (Figure 4A and B). Complete
deglycosylation of samples with peptide:N-glycosidase
(PNGase) F produced bands corresponding to deglycosy-
lated LAMPs (w50 kDa), but it did not eliminate the dif-
ference between pancreatitis and control (Figure 4A and B).
Of note, our data show that the Abs against the luminal part
of LAMPs (from Iowa Developmental Studies Hybridoma
Bank) do not recognize deglycosylated LAMPs, but the C-
terminal Abs do (Figure 4A and B). Thus, the fact that in
pancreatitis there is more LAMP immunoreactivity detected
with the luminal Abs than with the C-terminal Abs
(Figure 3) indicates that pancreatitis-induced decreases in
LAMP-1 and LAMP-2 are not due to their deglycosylation.
To determine whether LAMPs in pancreatitis are present
as fully mature glycans, we treated control and pancreatitis
samples with endoglycosidase H or Jack bean a-man-
nosidase, which cleave partially processed but not fully
mature glycans.31 LAMPs were insensitive to the action of
these enzymes (Figure 4A), indicating fully mature
Figure 3. Pancreatitis preferentially affects lysosome-associated membrane protein (LAMP) C terminus. LAMP levels
were measured by immunoblot in (A–C) whole-tissue homogenates and (D) lysosome-enriched fraction from pancreata of mice
with cerulein (CR) or choline-deficient, ethionine-supplemented diet (CDE) pancreatitis, using either Abs against the C terminus
of LAMP-1 (Abcam) and LAMP-2 (Sigma-Aldrich) or Abs that recognize the luminal part of LAMPs (Iowa Developmental
Studies Hybridoma Bank; see Materials and Methods). (C) LAMP band intensity was normalized to that of extracellular signal-
activated kinases (ERK) in the same sample, and the mean LAMP/ERK ratio in pancreatitis group was further normalized to
that in control (saline) group. Values are mean ± SEM (n ¼ 4 per group). *P < .05 versus control; #P < .05 versus the cor-
responding LAMP band intensity detected with C-terminal Ab. (D) Red and blue dashed lines indicate a shift in the position of
LAMP-2 band.
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pancreatitis. Also, there was no detectable shift in LAMP-2
electrophoretic mobility upon treatment of either control
or pancreatitis samples with neuraminidase (Figure 4C),
indicating no or very few terminal sialic acid residues in
LAMP-2. However, there was a slight shift in the electro-
phoretic mobility upon treatment with neuraminidase þ O-
glycanase (Figure 4C), indicating the presence of O-glycans.Cathepsin B Mediates the LAMP Decrease
in Pancreatitis
We next considered another possible mechanism of
LAMP degradation: their cleavage by lysosomal proteases.
Such a mechanism, regulating chaperone-mediated auto-
phagy, was shown for LAMP-2a cleavage by CatA.32,33 The
luminal part of LAMPs is largely protected against lysosomal
proteases by being heavily glycosylated; however, a shortregion near the boundary with the transmembrane domain
is less glycosylated and thus could be prone to proteolytic
cleavage in pathologic conditions (see below).
We specifically tested whether CatB could be involved in
LAMP degradation in pancreatitis. This cysteine protease
is important for pancreatitis because it mediates key
pathologic responses of this disease: the inappropriate,
intra-acinar trypsinogen activation and necrosis.6,23,26,34
Pharmacologic inhibition and genetic ablation of CatB
markedly ameliorate experimental pancreatitis.23,26,34
However, it is not known whether CatB has pathologic ac-
tions other than trypsinogen activation.
We first measured the effects of E-64d, a broad-
spectrum cysteine protease inhibitor, and CA-074Me, a se-
lective CatB inhibitor, on LAMP levels. For this, we used an
ex vivo model of pancreatitis,6,23 namely, pancreatic lobules
hyperstimulated with CCK-8. Both inhibitors largely pre-
vented pancreatitis-induced decreases in LAMP-1 and
Figure 4. Pancreatitis does not cause bulk lysosome-associated membrane protein (LAMP) deglycosylation. Cerulein
(CR) and L-arginine (Arg) pancreatitis were induced in (A) rats or (B, C) mice. Pancreatic tissue homogenates from control
(saline) and pancreatitic animals were treated with PNGase F (F), Jack bean a-mannosidase (J), endoglycosidase H (E),
neuraminidase (N), or neuraminidase plus O-glycanase (N/O), as described in Materials and Methods. LAMP-1 and LAMP-2
were analyzed by immunoblot using C-terminal or luminal Abs, as indicated. Numbers to the right are protein molecular
mass markers in kDa. (C) Red and blue dashed lines indicate a shift in the position of LAMP-2 band.
November 2015 LAMP-2 Deficiency Causes Pancreatitis 685LAMP-2 (Figure 5A and B; and data not shown). Differently,
the irreversible serine protease inhibitor AEBSF [4-(2-
aminoethyl)benzenesulfonyl fluoride] failed to prevent the
CCK-induced LAMP decrease (Figure 5C) although it
completely abrogated CCK-induced trypsinogen activation
(Figure 5D), as previously reported elsewhere.35 Thus, the
CCK/CR-induced LAMP decrease is not mediated by trypsin.
In vivo, we further found (Figure 5E) that in mice defi-
cient in CatB, CR pancreatitis caused essentially no decrease
in LAMPs. Differently, pancreatitis-induced decreases in
LAMPs were not abrogated by genetic ablation of another
cathepsin, CatD (Figure 5F). Interestingly, the basal
pancreatic LAMP levels were up-regulated in CatD/ mice
(Figure 5F).
Finally, we assessed whether CatB could directly cleave
LAMPs. Incubation of recombinant mouse LAMP-1 (rLAMP-
1) with active recombinant CatB caused a pronounced
decrease in the rLAMP-1 level (Figure 6A). The decrease
was much greater when detected with an Ab against C-
terminal 6His-tag [substituting for the transmembrane and
cytosolic domains (Met371–Ile406) in rLAMP-1; Figure 6E]
than with the luminal Ab (Figure 6A). There was no
decrease in rLAMP-1 when rCatB was omitted from the
incubation mix. Mass spectrometric analysis (see Materials
and Methods) showed that CatB cleaves LAMP-1 at several
sites close to the boundary between the luminal and the
transmembrane domains (Figure 6B–E). Of note, the cleav-
age site-predicting Web tool we used36 identifies more than
20 potential (>95% specific) sites for CatB cleavage in
LAMP-1, spread all over the luminal part of the molecule(not shown). However, only a few of those were detected by
MS in our in vitro assay, all clustered in a short region close
to the transmembrane domain (Figure 6B–E). This region (c.
Leu339 to Asn370 in LAMP-1) could, therefore, be suscep-
tible to cleavage in pancreatitis; it is less glycosylated than
the rest of the LAMPs luminal ectodomain. Interestingly, the
cleavage of LAMP-2a by CatA also occurs in this region, at a
site near the boundary between the luminal and trans-
membrane domains.33LAMP-2 Deficiency Causes Spontaneous
Pancreatitis
To assess the consequences of the LAMP decrease and
elucidate the role of LAMP-2 in acinar cell homeostasis, we
characterized in detail the exocrine pancreas damage in
LAMP-2 null mice. We find that these mice14,18 progressively
develop histopathologic changes characteristic of pancrea-
titis (Figure 7A). Accumulation in acinar cells of abnormally
large autolysosomes, seen with both light and electron mi-
croscopy, was the earliest manifestation of pancreatic dam-
age, already prominent in 1-month-old LAMP-2 null mice
(Figure 7A and F). Different from acinar cells, there was no
vacuole accumulation or other histologic abnormalities in
islets (Figure 7B). In accord with histology, LAMP-2 defi-
ciency did not increase the blood glucose (Figure 7C), indi-
cating little effect on the endocrine compartment. Acinar cell
vacuolization (Figure 7 A,F) in the LAMP-2 null pancreas was
associated with increases in microtubule-associated protein-
1 light chain 3-II (LC3-II), an autophagymarker that uniquely
Figure 5. Lysosome-
associated membrane
protein (LAMP) degrada-
tion in cerulein (CR)
pancreatitis is mediated
by cathepsin B (CatB).
LAMP levels were
measured by immunoblot,
using C-terminal Ab, in
(A–C) freshly prepared
pancreatic lobules incu-
bated with or without 100
nM cholecystokinin-8
(CCK-8) in the absence
and presence of (A) a
broad-spectrum cysteine
protease inhibitor E64d (50
mM), (B) CatB inhibitor
CA074Me (50 mM), or (C)
serine protease inhibitor
AEBSF [4-(2-aminoethyl)
benzenesulfonyl fluoride] (1
mM); and (E, F) in the
pancreas of wild type, CatB
/, or CatD/ mice with
CR pancreatitis. LAMP
band intensity was normal-
ized to that of extracellular
signal-activated kinase
(ERK) or actin in the same
sample. The data are
representative of several
immunoblots on at least
three preparations of lob-
ules or three mice of each
genotype. (D). Trypsin ac-
tivity was measured in
mouse acinar cells in-
cubated for 30 minutes with
or without 100 nM CCK-8
in the absence and pres-
ence of 1 mM AEBSF.
Values are mean ± SEM
from duplicate measure-
ments in two independent
experiments.
686 Mareninova et al Cellular and Molecular Gastroenterology and Hepatology Vol. 1, No. 6localizes to autophagosomal membranes,11,12,37,38 and p62/
SQSTM1 (sequestosome 1), a protein that is degraded
through autophagy37–39 (Figure 7E). [Of note, the absence of
LAMP-2 in the pancreas of LAMP-2 null mice was demon-
strated with the C-terminal Ab (Figure 7D), validating the
specificity of this Ab.]
Accumulation of enlarged autophagic vacuoles contain-
ing partially degraded cargo (in particular, remnants of or-
ganelles), and the increases in both LC3-II and p62 indicatedefective autophagic flux.10–12,38 These manifestations of
impaired autophagy in LAMP-2 null pancreas are similar to
those observed in wild-type pancreatitis (Figure 7E).6,8
Early acinar cell vacuolization in LAMP-2 null mice was
followed by other pathologic responses of pancreatitis: tis-
sue disorganization (Figure 7A), necrotic and apoptotic
acinar cell death (Figure 8A and B) associated with
compensatory proliferation (immunohistochemistry for
Ki67; Figure 8B and C), and the intrapancreatic trypsinogen
Figure 6. Mass spectrometry (MS) analysis of mouse recombinant lysosome-associated membrane protein 1 (LAMP-1)
peptides generated by cleavage with cathepsin B (CatB). (A). Recombinant (r) mouse LAMP-1 (rLAMP-1) was incubated for
1 hour at 37C with the indicated concentrations of active rCatB (see Materials and Methods). The rLAMP-1 level was
measured by immunoblot using either the luminal Ab or an Ab against C-terminal 6-His tag; rLAMP-1 band intensity was
normalized to that in the absence of rCatB. Numbers to the right are protein molecular mass markers in kDa. Representative of
two independent experiments, with similar results. (B, C). Mass spectrometry data for C-terminal fragments of rLAMP-1
generated by incubation with CatB. (D). Comparison of CatB cleavage sites detected by MS versus CatB cleavage sites in
mouse LAMP-1 predicted by the SitePrediction web tool (http://www.dmbr.ugent.be/prx/bioit2). (E). C-terminal amino acid
sequences of mouse LAMP-1 and rLAMP-1. Dashed lines indicate sites of rLAMP-1 cleavage by CatB detected by MS.
November 2015 LAMP-2 Deficiency Causes Pancreatitis 687activation (Figure 8B). LAMP-2 deficiency caused progres-
sive increase in inflammatory cell infiltration (Figure 8A),
which was predominantly macrophage but not neutrophil,
driven (Figure 9A–C), a characteristic of chronic pancrea-
titis. As shown by immunostaining for CD68, a pan-
macrophage/monocyte marker, and CD206, a marker of
M2a macrophages, LAMP-2 deficiency stimulated infiltration
of both proinflammatory M1 and profibrogenic M2 macro-
phages,40 with the former predominant (Figure 9A).
Immunohistochemical and immunoblot analyses showed
significant up-regulation of a-SMA, a marker of activated
stellate cells (Figure 9D, F, and G); however, there was no
increase in fibrosis, as evidenced by lack of positive tri-
chrome and collagen-1 staining (Figure 9D, E, and G). One
possible explanation is that LAMP-2 deficiency blocks
autophagy in stellate cells, resulting in their failure to pro-
duce extracellular matrix proteins. Indeed, loss of auto-
phagic function in hepatic stellate cells was recently shown
to reduce liver fibrogenesis.41LAMP-2 Maintains Pancreatic Acinar Cell
Homeostasis
LAMP-2 deficiency caused a marked decrease in diges-
tive enzymes’ pancreatic content, measured in both tissue
and isolated acinar cells (Figure 10A, D, and F). In particular,
amylase content decreased byw60%, which translated into
an approximately twofold increase in amylase release into
the circulation (although the absolute level of serum
amylase did not change; Figure 10B and C). Furthermore,
there was a w50% decrease in the average number of
zymogen granules per acinar cell in LAMP-2 null pancreas
(Figure 10D).
It is well established34 that physiologic CCK concentra-
tions stimulate, whereas its supramaximal concentrations
inhibit, amylase release from acinar cells, producing the
hallmark biphasic secretory response (Figure 10G and H).
We found that in LAMP-2 null acinar cells the basal
(unstimulated) amylase release was greater than in the wild
type (Figure 10G) and the CCK-induced amylase release was
Figure 7. Lysosome-
associated membrane
protein 2 (LAMP-2) ge-
netic ablation causes
impaired autophagy in
the exocrine pancreas.
(A). Toluidine-blue stained
pancreatic tissue sections
from LAMP-2 null (knock-
out) mice showing acinar
cell vacuolization, tissue
disorganization, and in-
flammatory cell infiltration.
Scale bar: 20 mm. (B)
Immunohistochemistry for
insulin in pancreas of
LAMP-2 knockout mice.
Note massive vacuoliza-
tion of acinar but not islet
cells. Scale bar: 50 mm.
(C). Serum glucose levels
in wild-type and LAMP-2
knockout mice. Values
are mean ± SEM (n ¼ 3
per group). (D, E). LAMP-
2, microtubule-associated
protein-1 light chain 3
(LC3), and p62/SQSTM1
(sequestosome 1) were
measured by immunoblot
in pancreata of LAMP-2
knockout mice and wild-
type mice with CR
pancreatitis. (F). Electron
micrographs showing
abnormally large autoly-
sosomes (AL) containing
partially degraded material
in pancreas of LAMP-2
knockout mice. ZG,
zymogen granules. Scale
bar: 2 mm. The data in B–
F are for 6-month-old
LAMP-2 knockout mice.
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was at both physiologic and supramaximal CCK concentra-
tions. The results in Figure 10 indicate a critical role for
LAMP-2 in regulating digestive enzyme secretion, the main
function of acinar cells.
Effects of LAMP-2 Genetic Ablation on Acute
Cerulein Pancreatitis
We next asked whether LAMP-2 deficiency affects the
classic acute CR pancreatitis model. Histopathologic mani-
festations of CR pancreatitis in LAMP-2 null mice (tissue
disorganization, necrosis, and especially acinar cell vacuo-
lization) were more pronounced than in the wild type
(Figure 11A), but this was primarily due to the severe basal
pancreatic damage in LAMP-2 null mice. The magnitude ofthe key pathologic responses caused by LAMP-2 deficiency
per se—necrosis, apoptosis (i.e., caspase-3 activation), and
macrophage infiltration—was similar to, or even greater
than, that induced by CR in wild-type pancreas (Figure 11).
Furthermore, the effects of LAMP-2 knockout and CR
(relative to wild-type control) were not additive
(Figure 11B, E, G, and H), indicating overlapping mecha-
nisms. CR-induced trypsin activity, a hallmark pathologic
response, was 4.2-fold in the wild type but only 3.1-fold in
the LAMP-2 null pancreas (Figure 11C).
The serum amylase increase was similar in wild-type
and LAMP-2 null mice with CR pancreatitis (Figure 11D);
however, the fact that pancreatic amylase content is mark-
edly decreased in LAMP-2 null mice (Figure 10A) compli-
cates interpretation of these data. Of note, the pattern of
Figure 8. Lysosome-associated membrane protein 2 (LAMP-2)–deficient mice spontaneously develop pancreatitis.
Pancreatitis responses were measured in LAMP-2 null mice (knockout) at (A) indicated age or (B, C) 6 months of age. Values
are mean ± SEM from at least three mice in each group. *P < .05 versus all other groups. Scale bar: 20 mm.
November 2015 LAMP-2 Deficiency Causes Pancreatitis 689CR-induced inflammatory cell infiltrate differs between the
wild-type and LAMP-2 null pancreas. Compared to the wild
type, the LAMP-2 null mice with CR pancreatitis displayed
greater macrophage infiltration identified by CD68 and
CD206 markers (Figure 11G and H). In contrast, recruitment
of neutrophils was inhibited, as evidenced by w50% lesser
MPO activity (Figure 11F). Thus, the inflammatory response
of CR pancreatitis in LAMP-2 null mice is shifted toward that
of chronic disease. The results in Figure 11 show that,
overall, CR-induced responses are blunted in LAMP-2 null
mice (as compared with the wild type).Discussion
LAMPs are critical to the function of lysosomes.15 We
found marked decreases in both LAMP-1 and LAMP-2 in five
different rat and mouse models of pancreatitis, the ex vivo
model of hyperstimulated acinar cells, and in human
pancreatitis. In addition, the LAMP decrease has been
observed in ethanol þ lipopolysaccharide model of alcoholic
pancreatitis.7 Same as in the normal pancreas, LAMPs in
pancreatitis localize to lysosomes and autolysosomes, but in
pancreatitis their levels in lysosomes are greatly decreased.
There is no such decrease in LIMP-2, a member of a
different family of lysosomal membrane proteins, indicating
a specific effect of pancreatitis on LAMPs.Our results are evidence against LAMPs’ bulk deglyco-
sylation as the mechanism underlying their decrease in
pancreatitis. Instead, the results indicate that pancreatitis
causes the degradation of LAMPs, which involves CatB-
mediated cleavage of the luminal part of LAMP molecule
close to the transmembrane domain. This conclusion is
supported by several lines of evidence: 1) comparative
immunoblot analysis using C-terminal versus luminal Abs,
2) the absence of pancreatitis-induced LAMP decrease in
CatB-deficient mice, and 3) MS analysis of in vitro CatB
cleavage of recombinant LAMP-1.
In normal conditions, LAMPs in the lysosome are pro-
tected from cleavage by acid hydrolases. One mechanism
mediating this protection is that LAMP molecule is heavily
glycosylated;15,17,30 another mechanism is that hydrolases
are normally present in the lumen as large multiprotein
complexes spatially separated from LAMPs.42,43 We have
shown6,8 that experimental pancreatitis causes alterations
in CatB processing/maturation, resulting in a decrease in its
fully mature form and concomitant accumulation of the in-
termediate and pro-forms. One may speculate that in
pancreatitis the abnormal maturation of cathepsins (e.g.,
altered balance between single- versus double-chain active
CatB forms44) affects their localization in the lumen and
interactions with other lysosomal proteins, resulting in
CatB-mediated cleavage of LAMPs. This renders LAMPs
Figure 9. Lysosome-associated membrane protein 2 (LAMP-2) deficiency causes macrophage infiltration and stellate
cell activation but not fibrosis in pancreas. Immunofluorescent (A), histochemical (B, E), and immunohistochemical (D)
staining of pancreatic tissue sections from 6-month-old wild-type and LAMP-2 knockout mice for markers of macrophages
(CD68 and CD206), neutrophils [chloroacetate esterase (CAE)], activated stellate cells (a-SMA), and fibrosis (Goldner trichrome
and collagen-1). In (A), nuclei stained with 40,6-diamidino-2-phenylindole (DAPI). (C). Electron micrograph showing abundant
macrophages (M) in pancreas of a 6-month-old LAMP-2 knockout mouse. (F) Immunoblot for a-SMA (a-smooth muscle actin)
in pancreas of wild-type and LAMP-2 knockout mice. (G). a-SMA and collagen-1 were quantified on pancreatic tissue sections
as the percentage of the positive area. Values are mean ± SEM (n ¼ 3 per group). *P < .05 versus wild type. Scale bars: 10 mm
(A, B, D, E) and 2 mm (C).
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protease(s) work in concert with CatB to cause LAMP
degradation in pancreatitis, as is the case in CatA-mediated
degradation of LAMP-2a.32,33 However, the site-specific ac-
tion of CatB is critical for LAMP degradation, as pancreatitis
causes no decrease in LAMPs in CatB-deficient mice.
The role of CatB as a key mediator of the pathologic,
intra-acinar trypsinogen activation in pancreatitis is well
established.6,23,26,34 Our results reveal another mechanism
through which alterations in CatB may lead to pancreas
damage, namely, through LAMP degradation.
LAMP-2 deficiency causes accumulation of large auto-
phagic vacuoles in several organs and results in cardiomy-
opathy, representing a mouse model of Danon disease.14,18Differently, mice deficient in LAMP-1 do not develop overt
pathologic changes, likely because of compensatory LAMP-2
upregulation. In this regard, it is noteworthy that pancrea-
titis causes marked decreases in both LAMP-1 and LAMP-2.
Although vacuole accumulation has been reported in
pancreas of LAMP-2 null mice,18 the consequences of LAMP
deficiency for exocrine pancreas have not been explored.
Here, we find that LAMP-2 null mice progressively develop
major responses of pancreatitis. Our data indicate that
LAMP-2 deficiency primarily targets the exocrine compart-
ment, as LAMP-2 null islets do not exhibit vacuolization or
other histopathologic alterations. Autophagy impairment is
the earliest pathologic response, already prominent in
acinar cells of 1-month-old LAMP-2 null mice by
Figure 10. Lysosome-associated membrane protein 2 (LAMP-2) maintains acinar cell homeostasis. (A–E). Intra-
pancreatic content of (A) amylase (immunoblot) and (D) trypsinogen [enterokinase assay (see Materials and Methods)], (B)
serum amylase level, and (C) ratio to intrapancreatic amylase, and acinar cell zymogen granules (ZG) number (E) were
measured in 6-month-old wild-type and LAMP-2 knockout mice. (E) The average ZG number per acinar cell was quantified on
electron micrographs of pancreatic tissue sections. (F–H) Intracellular amylase content (F), and the basal and cholecystokinin
(CCK)-induced amylase release (G, H) were measured in pancreatic acini isolated from wild-type and LAMP-2 knockout mice
and incubated for 30 minutes with and without CCK-8 at indicated concentrations. (H) Amylase release from wild-type or
knockout mice was normalized to that in the absence of CCK. Values are mean ± SEM; n ¼ 3–4 mice of each genotype (B–D),
10–12 cells per group (E), 3–4 acinar cell preparations per group (F–H). *P < .05 versus wild type.
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degraded cargo. Defective autophagic flux is also manifested
by increases in both LC3-II and p62. By the age of 6 months,
LAMP-2 null mice develop severe pancreatic damage char-
acterized by tissue disorganization, acinar cell necrosis and
apoptosis, massive macrophage infiltration, and stellate cell
activation (i.e., a-SMA up-regulation). These pathologic re-
sponses are characteristic of chronic pancreatitis; however,
despite stellate cell activation LAMP-2-deficient mice do not
develop pancreatic fibrosis. One reason for this could be
inhibition of autophagy in LAMP-deficient pancreatic stel-
late cells. Autophagy provides a critical source of energy
necessary for activated stellate cells to produce extracellular
matrix proteins,45 and blockade of autophagy in hepatic
stellate cells was recently shown to reduce liver fibro-
genesis and matrix deposition in experimental hepatitis
models.41 Further studies are needed to determine the role
of lysosomes and autophagy in pancreatic stellate cells for
the development of fibrosing response of pancreatitis.
Another underlying mechanism could be the predominanceof M1 macrophages versus the profibrogenic M2 macro-
phages in LAMP-2 null pancreas.
LAMP-2 deficiency causes a marked decrease in
pancreatic amylase and trypsinogen content; furthermore, it
increases the basal and inhibits the CCK-induced amylase
release from acinar cells. The results reveal a major role for
LAMP-2—more broadly, normal lysosomal/autophagic
pathways—in regulating digestive enzyme secretion, the
main function of exocrine pancreas.
To determine whether LAMP deficiency makes pancreas
more susceptible to acute insult, we subjected LAMP-2 null
mice to one episode of CR pancreatitis. Overall, our results
indicate that chronic pancreas damage blunts the effects of
acute pancreatitis, which correlates with clinical data.46,47
Most of CR-induced responses in LAMP-2 null mice are
“muted,” as compared to the wild type. In particular, the
effects of LAMP-2 knockout per se and CR on acinar cell
vacuolization, necrosis, apoptosis are not additive (relative
to wild-type control). Such overlap supports the notion of a
pathogenic role of a LAMP decrease in CR-induced and other
Figure 11. Effects of lysosome-associated membrane protein (LAMP) deficiency on acute cerulein (CR) pancreatitis
responses. CR pancreatitis was induced as described inMaterials and Methods. Histopathologic changes (A; H&E staining) and
other parameters of pancreatitis were measured in pancreata (A, C–H) and serum (B) of wild-type and LAMP-2 knockout mice.
MPO, myeloperoxidase. Values are mean ± SEM from 3–4 mice per group. *P < .05 versus wild-type saline control; #P < .05
versus wild-type CR; $P < .05 versus LAMP-2 knockout saline control.
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disease). Of note, trypsin activity in LAMP-2 null pancreas is
further increased by CR, indicating the involvement of
LAMP-2 independent mechanism(s). One such likely mech-
anism, mediating trypsinogen activation, is the aberrant
(global and sustained) Ca2þ signal.34 Also noteworthy is the
suppression of neutrophilic infiltration in CR-treated LAMP-
2 null mice, indicating a shift toward macrophage-driven,
“chronic” inflammatory response.
In sum, our results show that lysosomal dysfunction,
manifest by LAMP degradation, is a common event in
various experimental models and human pancreatitis.
Further, LAMP-2 is critical to acinar cell function, and its
genetic ablation causes impaired autophagy and the devel-
opment of pancreatitis. A recent study (published after the
submission of this report) showed that pancreas-specific
genetic ablation of the key autophagy mediator Atg5 cau-
ses spontaneous pancreatitis.48,49 However, no decrease (or
inactivating mutation) in Atg5 has been detected in human
disease. Differently, LAMP-2 pancreatic level is greatly
decreased in human pancreatitis. It has also been reported50
that pancreas-specific ablation of the inhibitor of kB kinase
a (IKKa), a component of the IKK kinase complex respon-
sible for nuclear factor kB (NF-kB) activation, causes acinar
cell damage progressing from vacuole accumulation to
chronic pancreatitis. This effect is unrelated to NF-kB;
instead, IKKa deficiency impairs the completion of auto-
phagy in acinar cell.50 In accord with these findings, our
study supports the notion8,9 that disordering of lysosomal
and autophagic pathways is a key pathogenic mechanism
initiating and driving pancreatitis. Further, it provides evi-
dence that decrease/degradation of LAMPs, particularly
LAMP-2, plays an important role in this mechanism. Thenew genetic model of pancreatitis caused by LAMP-2 defi-
ciency will help us to understand why the exocrine pancreas
is particularly malleable to lysosomal and autophagy dys-
functions as well as to elucidate the mechanisms that link
these dysfunctions to pancreatitis pathologies.References
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